Login

Dapagliflozin-3-O-β-D-glucuronide

CAT:
804-HY-125156-02
Size:
1 mg
Price:
Ask
For price, please contact [email protected]
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Dapagliflozin-3-O-β-D-glucuronide - image 1

Dapagliflozin-3-O-β-D-glucuronide

  • Product Name Alternative: BMS-801576
  • CAS Number: 1351438-75-9
  • UNSPSC Description: Dapagliflozin-3-O-β-D-glucuronide (BMS-801576) is the metabolite of Dapagliflozin (HY-10450), and is formed in the liver and kidney by uridine diphosphate glucuronosyltransferase-1A9 (UGT1A9). Dapagliflozin is a selective inhibitor for SGLT2, that can be used to improve glycemic control and attenuate type 2 diabetes[1].
  • Target Antigen: Endogenous Metabolite
  • Type: Reference compound
  • Related Pathways: Metabolic Enzyme/Protease
  • Field of Research: Metabolic Disease
  • Assay Protocol: https://www.medchemexpress.com/dapagliflozin-3-o-β-d-glucuronide.html
  • Purity: 99.0
  • Solubility: DMSO : 1 mg/mL (ultrasonic;warming)
  • Smiles: ClC1=C(CC2=CC=C(C=C2)OCC)C=C([C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O[C@]4([C@@H]([C@H]([C@@H]([C@H](O4)C(O)=O)O)O)O)[H])O)C=C1
  • Molecular Weight: 585.00
  • References & Citations: [1]Kasichayanula S, et al., Clinical pharmacokinetics and pharmacodynamics of dapagliflozin, a selective inhibitor of sodium-glucose co-transporter type 2. Clin Pharmacokinet. 2014 Jan;53(1):17-27.
  • Shipping Conditions: Blue Ice
  • Storage Conditions: -20°C (Powder, protect from light, stored under nitrogen)
  • Clinical Information: No Development Reported